Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Prothrombin Time"" wg kryterium: Temat


Tytuł :
Association Between the Prothrombin Time-International Normalized Ratio and Concomitant Use of Antibiotics in Warfarin Users: Focus on Type of Antibiotic and Susceptibility of Bacteroides fragilis to Antibiotics.
Autorzy :
Yagi T; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan.; Department of Medicine Solna, Centre for Pharmacoepidemiology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Naito T; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Kato A; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Hirao K; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Kawakami J; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Pokaż więcej
Źródło :
The Annals of pharmacotherapy [Ann Pharmacother] 2021 Feb; Vol. 55 (2), pp. 157-164. Date of Electronic Publication: 2020 Jul 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
International Normalized Ratio*
Prothrombin Time*
Anti-Bacterial Agents/*adverse effects
Anticoagulants/*administration & dosage
Blood Coagulation/*drug effects
Warfarin/*administration & dosage
Aged ; Anti-Bacterial Agents/administration & dosage ; Anti-Bacterial Agents/therapeutic use ; Anticoagulants/therapeutic use ; Bacterial Infections/drug therapy ; Bacterial Infections/microbiology ; Bacteroides fragilis/drug effects ; Cohort Studies ; Drug Interactions ; Female ; Fluoroquinolones/administration & dosage ; Fluoroquinolones/adverse effects ; Fluoroquinolones/therapeutic use ; Hemorrhage/chemically induced ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Warfarin/therapeutic use ; beta-Lactams/administration & dosage ; beta-Lactams/adverse effects ; beta-Lactams/therapeutic use
Czasopismo naukowe
Tytuł :
A rare case of prothrombin time prolongation.
Autorzy :
Camilleri E; Center for Atherothrombotic Disease, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Maggini N; Center for Atherothrombotic Disease, Careggi University Hospital, Florence, Italy.
Piccica M; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Botta A; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Poli D; Center for Atherothrombotic Disease, Careggi University Hospital, Florence, Italy. .
Pokaż więcej
Źródło :
Internal and emergency medicine [Intern Emerg Med] 2021 Jan; Vol. 16 (1), pp. 237-239. Date of Electronic Publication: 2020 Jun 17.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Prothrombin Time*
Anti-Bacterial Agents/*adverse effects
Aztreonam/*adverse effects
Bacteremia/*drug therapy
Blood Coagulation Disorders/*chemically induced
Klebsiella Infections/*drug therapy
Acute Kidney Injury/therapy ; Bacteremia/microbiology ; Blood Coagulation Disorders/genetics ; Carcinoma, Squamous Cell/surgery ; Female ; Gastrostomy ; Humans ; Klebsiella Infections/microbiology ; Laryngeal Neoplasms/surgery ; Middle Aged ; Platelet Count ; Postoperative Complications/therapy ; Renal Dialysis
Raport
Tytuł :
Prothrombin Time ratio can predict mortality in severe pediatric trauma: Study in a French trauma center level 1.
Autorzy :
Hochart A; CHU Lille, Institut d'Hématologie et de Transfusion, F-59000 Lille, France. Electronic address: .
Momal R; CHU de Lille, Pôle d'anesthésie-réanimation, Lille F-59000, France. Electronic address: .
Garrigue-Huet D; CHU de Lille, Pôle d'anesthésie-réanimation, Lille F-59000, France; CHU Lille, Pôle de l'Urgence, Lille F-59000, France. Electronic address: .
Drumez E; Univ. Lille, CHU Lille, Unité de biostatistiques, EA 2694, F-59000 Lille, France. Electronic address: .
Susen S; CHU Lille, Institut d'Hématologie et de Transfusion, F-59000 Lille, France. Electronic address: .
Bijok B; CHU de Lille, Pôle d'anesthésie-réanimation, Lille F-59000, France; CHU Lille, Pôle de l'Urgence, Lille F-59000, France. Electronic address: .
Pokaż więcej
Źródło :
The American journal of emergency medicine [Am J Emerg Med] 2020 Oct; Vol. 38 (10), pp. 2041-2044. Date of Electronic Publication: 2020 Jul 04.
Typ publikacji :
Journal Article
MeSH Terms :
Predictive Value of Tests*
Prothrombin Time/*statistics & numerical data
Wounds and Injuries/*mortality
Adolescent ; Child ; Child, Preschool ; Female ; France/epidemiology ; Humans ; Infant ; Male ; Mortality/trends ; Pediatrics/instrumentation ; Pediatrics/methods ; Pediatrics/trends ; Prothrombin Time/methods ; Retrospective Studies ; Trauma Centers/organization & administration ; Trauma Centers/statistics & numerical data ; Wounds and Injuries/blood ; Wounds and Injuries/complications
Czasopismo naukowe
Tytuł :
Evaluation of a new thromboplastin reagent STA-NeoPTimal on a STA R Max analyzer for the measurement of prothrombin time, international normalized ratio and extrinsic factor levels.
Autorzy :
Mullier F; Department of Laboratory Medicine, Université catholique de Louvain, CHU UCL Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Yvoir, Belgium.
Paridaens MS; Queen Astrid Military Hospital in Brussels, Brussels, Belgium.
Evrard J; Department of Pharmacy, Université de Namur, Namur, Belgium.
Baudar J; Department of Laboratory Medicine, Université catholique de Louvain, CHU UCL Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Yvoir, Belgium.
Guldenpfennig M; Department of Laboratory Medicine, Université catholique de Louvain, CHU UCL Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Yvoir, Belgium.
Devroye C; Department of Laboratory Medicine, Université catholique de Louvain, CHU UCL Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Yvoir, Belgium.
Miller L; Department of Laboratory Medicine, Université catholique de Louvain, CHU UCL Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Yvoir, Belgium.
Chatelain B; Department of Laboratory Medicine, Université catholique de Louvain, CHU UCL Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Yvoir, Belgium.
Lessire S; Department of Anesthesiology, Université catholique de Louvain, CHU UCL Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Yvoir, Belgium.
Jacqmin H; Department of Laboratory Medicine, Université catholique de Louvain, CHU UCL Namur, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), Yvoir, Belgium.
Pokaż więcej
Źródło :
International journal of laboratory hematology [Int J Lab Hematol] 2020 Oct; Vol. 42 (5), pp. 650-660. Date of Electronic Publication: 2020 May 19.
Typ publikacji :
Journal Article
MeSH Terms :
Thromboplastin*
International Normalized Ratio/*instrumentation
International Normalized Ratio/*methods
Prothrombin Time/*instrumentation
Prothrombin Time/*methods
Blood Coagulation/drug effects ; Blood Coagulation Tests/instrumentation ; Blood Coagulation Tests/methods ; Blood Coagulation Tests/standards ; Humans ; International Normalized Ratio/standards ; Liver Failure/blood ; Liver Failure/diagnosis ; Preoperative Period ; Prothrombin Time/standards ; Reproducibility of Results ; Sensitivity and Specificity ; Vitamin K/administration & dosage
Czasopismo naukowe
Tytuł :
Impaired immune and coagulation systems may be early risk factors for COVID-19 patients: A retrospective study of 118 inpatients from Wuhan, China.
Autorzy :
Qin ZJ; Department of Intensive Care Unit.
Liu L; Department of Infection Management, Sichuan Provincial Orthopedic Hospital, Chengdu, Sichuan.
Sun Q; Department of Intensive Care Unit.
Li X; Department of Intensive Care Unit.
Luo JF; Department of Gastrointestinal Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei.
Liu JS; Department of Gastrointestinal Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei.
Liu D; Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, China.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2020 Aug 28; Vol. 99 (35), pp. e21700.
Typ publikacji :
Journal Article
MeSH Terms :
Coronavirus Infections*/blood
Coronavirus Infections*/immunology
Coronavirus Infections*/mortality
Leukocyte Count*/methods
Leukocyte Count*/statistics & numerical data
Pandemics*
Pneumonia, Viral*/blood
Pneumonia, Viral*/immunology
Pneumonia, Viral*/mortality
Prothrombin Time*/methods
Prothrombin Time*/statistics & numerical data
Fibrin Fibrinogen Degradation Products/*analysis
Procalcitonin/*analysis
Adult ; Aged ; Betacoronavirus ; COVID-19 ; China/epidemiology ; Female ; Hospital Mortality ; Hospitalization/statistics & numerical data ; Humans ; Male ; Predictive Value of Tests ; Prognosis ; Retrospective Studies ; Risk Assessment/methods ; Risk Factors ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Association of marked prolongation of prothrombin time-international normalized ratio with warfarin and endoscopic nasobiliary drainage for biliary fistula after left hemihepatectomy.
Autorzy :
Nakazawa T; Division of Pharmacy, Chiba University Hospital, Chiba-shi, Japan.
Yamazaki S; Division of Pharmacy, Chiba University Hospital, Chiba-shi, Japan.
Uchida M; Division of Pharmacy, Chiba University Hospital, Chiba-shi, Japan.
Suzuki T; Division of Pharmacy, Chiba University Hospital, Chiba-shi, Japan.
Nakamura T; Division of Pharmacy, Chiba University Hospital, Chiba-shi, Japan.
Takayashiki T; Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba-shi, Japan.
Ohtsuka M; Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba-shi, Japan.
Ishii I; Division of Pharmacy, Chiba University Hospital, Chiba-shi, Japan.
Pokaż więcej
Źródło :
Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2020 Aug; Vol. 45 (4), pp. 815-818. Date of Electronic Publication: 2020 Mar 24.
Typ publikacji :
Case Reports
MeSH Terms :
International Normalized Ratio*
Prothrombin Time*
Biliary Fistula/*therapy
Drainage/*adverse effects
Hepatectomy/*adverse effects
Warfarin/*adverse effects
Aged ; Drug Interactions ; Endoscopy ; Humans ; Male ; Vitamin K Deficiency/complications
Raport
Tytuł :
[The Effect of Increased Free Concentrations of Warfarin Due to Protein-binding Substitution in a Combination of Tolvaptan on the PT-INR].
Autorzy :
Saito M; Department of Pharmacy, Tosei General Hospital.; Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University.
Maeda T; College of Pharmacy, Kinjo Gakuin University.
Ichihara T; Department of Emergency Medicine, Tosei General Hospital.
Iwao T; Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University.
Suzuki T; Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University.
Pokaż więcej
Źródło :
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan [Yakugaku Zasshi] 2020 Oct 01; Vol. 140 (10), pp. 1269-1274. Date of Electronic Publication: 2020 Jul 20.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Interactions*
International Normalized Ratio*
Prothrombin Time*
Anticoagulants/*blood
Tolvaptan/*pharmacology
Warfarin/*blood
Warfarin/*pharmacology
Administration, Oral ; Aged ; Aged, 80 and over ; Albumins/metabolism ; Anticoagulants/administration & dosage ; Dose-Response Relationship, Drug ; Female ; Humans ; In Vitro Techniques ; Male ; Middle Aged ; Protein Binding ; Time Factors ; Tolvaptan/administration & dosage ; Warfarin/administration & dosage ; Warfarin/metabolism
Czasopismo naukowe
Tytuł :
New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GARFIELD-AF.
Autorzy :
Goto S; Department of Cardiology, Keio University School of Medicine, Shinanomachi 35, Shinjuku 160-8582, Tokyo, Japan.
Goto S; Department of Medicine (Cardiology), Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan.
Pieper KS; Department of Clinical Research, Thrombosis Research Institute, Emmanuel Kaye Building, Manresa Road, Chelsea, London SW3 6LR, UK.
Bassand JP; Department of Clinical Research, Thrombosis Research Institute, Emmanuel Kaye Building, Manresa Road, Chelsea, London SW3 6LR, UK.; Department of Cardiology, University of Besançon Boulevard Fleming, 25000 Besançon, France.
Camm AJ; Cardiology Clinical Academic Group, Molecular & Clinical Sciences Institute, St. George's University of London, Cranmer Terrace, Tooting, London, UK.
Fitzmaurice DA; Department of Cardio-respiratory Primary Care, Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK.
Goldhaber SZ; Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.
Haas S; Formerly Klinikum rechts der Isar, Technical University of Munich, Normannenstr. 34a, Munich 80333, Germany.
Parkhomenko A; National Scientific Center, Strazhesko Institute of Cardiology, 5 Narodnogo Opolcheniya Street, Kiev 03680, Ukraine.
Oto A; Department of Cardiology, Memorial Ankara Hospital, Sihhiye, 06100, Ankara, Turkey.
Misselwitz F; Therapeutic areas Thrombosis & Hematology, Bayer AG, Müllerstraße 178, 13353 Berlin, Germany.
Turpie AGG; Department of Medicine, McMaster University, 237 Barton St E Hamilton, Ontario L8L 2X2, Canada.
Verheugt FWA; Department of Cardiology, Onze Lieve Vrouwe Gasthuis (OLVG), Oosterpark 9, NL-1091-AC Amsterdam, Netherlands.
Fox KAA; Edinburgh Centre for Cardiovascular Science, University of Edinburgh, Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, UK.
Gersh BJ; Department of Cardiovascular Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA.
Kakkar AK; Department of Clinical Research, Thrombosis Research Institute, Emmanuel Kaye Building, Manresa Road, Chelsea, London SW3 6LR, UK.; Department of Surgery, University College London, Gower St, Bloomsbury, London WC1E 6BT, UK.
Pokaż więcej
Źródło :
European heart journal. Cardiovascular pharmacotherapy [Eur Heart J Cardiovasc Pharmacother] 2020 Sep 01; Vol. 6 (5), pp. 301-309.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms :
Drug Monitoring*
Drug Therapy, Computer-Assisted*
International Normalized Ratio*
Neural Networks, Computer*
Prothrombin Time*
Anticoagulants/*administration & dosage
Atrial Fibrillation/*drug therapy
Blood Coagulation/*drug effects
Stroke/*prevention & control
Vitamin K/*antagonists & inhibitors
Administration, Oral ; Aged ; Aged, 80 and over ; Anticoagulants/adverse effects ; Atrial Fibrillation/blood ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/mortality ; Databases, Factual ; Female ; Hemorrhage/chemically induced ; Humans ; Male ; Predictive Value of Tests ; Prospective Studies ; Registries ; Reproducibility of Results ; Risk Assessment ; Risk Factors ; Stroke/diagnosis ; Stroke/mortality ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Vitamin K2 (Menaquinone-7) supplementation does not affect vitamin K-dependent coagulation factors activity in healthy individuals.
Autorzy :
Ren R; Department of Hematology, Affiliated Hospital of North Sichuan Medical College, Nanchong.
Liu J; Department of Hematology, Affiliated Hospital of Southwest Jiaotong University, Chengdu, Sichuan, China.
Cheng G; Department of Hematology, Affiliated Hospital of Southwest Jiaotong University, Chengdu, Sichuan, China.
Tan J; Department of Hematology, Affiliated Hospital of Southwest Jiaotong University, Chengdu, Sichuan, China.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2021 Jun 11; Vol. 100 (23), pp. e26221.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Coagulation Factors/*drug effects
Dietary Supplements/*standards
Vitamin K 2/*pharmacology
Adult ; Antifibrinolytic Agents/pharmacology ; Antifibrinolytic Agents/therapeutic use ; Blood Coagulation Factors/analysis ; Dietary Supplements/statistics & numerical data ; Factor IX/analysis ; Factor IX/drug effects ; Factor VII/analysis ; Factor VII/drug effects ; Factor X/analysis ; Factor X/drug effects ; Female ; Healthy Volunteers/statistics & numerical data ; Humans ; Male ; Partial Thromboplastin Time/methods ; Partial Thromboplastin Time/statistics & numerical data ; Prothrombin/analysis ; Prothrombin/drug effects ; Prothrombin Time/methods ; Prothrombin Time/statistics & numerical data ; Thrombin Time/methods ; Thrombin Time/statistics & numerical data ; Vitamin K 2/therapeutic use
Czasopismo naukowe
Tytuł :
Bias and uncertainty of the International Normalized Ratio determined with a whole blood point-of-care prothrombin time test device by comparison to a new International Standard for thromboplastin.
Autorzy :
van den Besselaar AMHP; Coagulation Reference Laboratory, Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: .
van Rijn CJJ; Coagulation Reference Laboratory, Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Abdoel CF; Coagulation Reference Laboratory, Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Cobbaert CM; Coagulation Reference Laboratory, Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, the Netherlands.
Pokaż więcej
Źródło :
Thrombosis research [Thromb Res] 2021 Jun; Vol. 202, pp. 1-7. Date of Electronic Publication: 2021 Feb 25.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Point-of-Care Systems*
Thromboplastin*
Anticoagulants/pharmacology ; Anticoagulants/therapeutic use ; Drug Monitoring ; Humans ; International Normalized Ratio ; Netherlands ; Prothrombin Time ; Uncertainty
Czasopismo naukowe
Tytuł :
The prognostic value of routine coagulation tests for patients with heat stroke.
Autorzy :
Xing L; Medical School of Chinese PLA, No. 28, Fuxing Road, Beijing 100853, China; Department of Emergency, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Liu SY; Medical School of Chinese PLA, No. 28, Fuxing Road, Beijing 100853, China.
Mao HD; Medical School of Chinese PLA, No. 28, Fuxing Road, Beijing 100853, China.
Zhou KG; Department of Emergency, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Song Q; Medical School of Chinese PLA, No. 28, Fuxing Road, Beijing 100853, China. Electronic address: .
Cao QM; Department of Emergency, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło :
The American journal of emergency medicine [Am J Emerg Med] 2021 Jun; Vol. 44, pp. 366-372. Date of Electronic Publication: 2020 Apr 22.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Blood Coagulation Tests*
Heat Stroke/*blood
Heat Stroke/*mortality
Adult ; China/epidemiology ; Female ; Humans ; International Normalized Ratio ; Male ; Partial Thromboplastin Time ; Prognosis ; Prothrombin Time ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
Blood coagulation parameter abnormalities in hospitalized patients with confirmed COVID-19 in Ethiopia.
Autorzy :
Araya S; Department of Medical Laboratory Sciences, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.; Department of Medical Laboratory, Millennium COVID-19 Treatment and Care Centre, St. Paual Millennium Medical College, Addis Ababa, Ethiopia.
Mamo MA; Department of Medical Laboratory Sciences, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.; Department of Medical Laboratory, Millennium COVID-19 Treatment and Care Centre, St. Paual Millennium Medical College, Addis Ababa, Ethiopia.
Tsegay YG; Department of Medical Biotechnology, Institute of Biotechnology, University of Gondar, Gondar, Ethiopia.; Department of Research and Development Center, College of Health Sciences, Defense University, Addis Ababa, Ethiopia.
Atlaw A; Department of Medical Laboratory, Millennium COVID-19 Treatment and Care Centre, St. Paual Millennium Medical College, Addis Ababa, Ethiopia.
Aytenew A; Department of Medical Laboratory, Millennium COVID-19 Treatment and Care Centre, St. Paual Millennium Medical College, Addis Ababa, Ethiopia.
Hordofa A; Department of Medical Laboratory, Millennium COVID-19 Treatment and Care Centre, St. Paual Millennium Medical College, Addis Ababa, Ethiopia.
Negeso AE; Department of Medical Laboratory Sciences, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Wordofa M; Department of Medical Laboratory Sciences, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Niguse T; Department of Medical Laboratory Sciences, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Cheru M; Department of Medical Laboratory Sciences, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Tamir Z; Department of Medical Laboratory Sciences, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2021 Jun 21; Vol. 16 (6), pp. e0252939. Date of Electronic Publication: 2021 Jun 21 (Print Publication: 2021).
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Severity of Illness Index*
COVID-19/*diagnosis
Thrombocytopenia/*epidemiology
Adolescent ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; COVID-19/blood ; COVID-19/complications ; COVID-19/mortality ; Child ; Child, Preschool ; Critical Illness ; Cross-Sectional Studies ; Ethiopia/epidemiology ; Hospitalization ; Humans ; International Normalized Ratio ; Middle Aged ; Partial Thromboplastin Time ; Platelet Count ; Prognosis ; Prospective Studies ; Prothrombin Time ; Risk Factors ; SARS-CoV-2/isolation & purification ; Sex Factors ; Thrombocytopenia/blood ; Thrombocytopenia/diagnosis ; Thrombocytopenia/etiology ; Young Adult
Czasopismo naukowe
Tytuł :
Potent Cyclic Peptide Inhibitors of FXIIa Discovered by mRNA Display with Genetic Code Reprogramming.
Autorzy :
Ford DJ; School of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia.; Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney, Sydney, New South Wales 2006, Australia.
Duggan NM; School of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia.; Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney, Sydney, New South Wales 2006, Australia.
Fry SE; School of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia.; Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney, Sydney, New South Wales 2006, Australia.
Ripoll-Rozada J; IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135 Porto, Portugal.; Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.
Agten SM; Department of Biochemistry, University of Maastricht, Cardiovascular Research Institute Maastricht (CARIM), Universiteitssingel 50, 6229 ER Maastricht, The Netherlands.
Liu W; Department of Chemistry, Graduate School of Science, The University of Tokyo, 7-3-1, Hongo, Tokyo 113-0033, Japan.
Corcilius L; School of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia.; Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney, Sydney, New South Wales 2006, Australia.
Hackeng TM; Department of Biochemistry, University of Maastricht, Cardiovascular Research Institute Maastricht (CARIM), Universiteitssingel 50, 6229 ER Maastricht, The Netherlands.
van Oerle R; Department of Biochemistry, University of Maastricht, Cardiovascular Research Institute Maastricht (CARIM), Universiteitssingel 50, 6229 ER Maastricht, The Netherlands.
Spronk HMH; Department of Biochemistry, University of Maastricht, Cardiovascular Research Institute Maastricht (CARIM), Universiteitssingel 50, 6229 ER Maastricht, The Netherlands.
Ashhurst AS; School of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia.; Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney, Sydney, New South Wales 2006, Australia.; School of Medical Sciences, Faculty of Medicine and Health, Sydney, New South Wales 2006, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales 2006, Australia.
Mini Sasi V; Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, Australian National University, Canberra, ACT 0200, Australia.; Research School of Chemistry, Australian National University, Canberra, ACT 0200, Australia.
Kaczmarski JA; Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, Australian National University, Canberra, ACT 0200, Australia.; Research School of Chemistry, Australian National University, Canberra, ACT 0200, Australia.
Jackson CJ; Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, Australian National University, Canberra, ACT 0200, Australia.; Research School of Chemistry, Australian National University, Canberra, ACT 0200, Australia.
Pereira PJB; IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135 Porto, Portugal.; Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.
Passioura T; School of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia.; Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney, Sydney, New South Wales 2006, Australia.; Department of Chemistry, Graduate School of Science, The University of Tokyo, 7-3-1, Hongo, Tokyo 113-0033, Japan.; School of Life and Environmental Sciences, The University of Sydney, Sydney, NSW 2006, Australia.; Sydney Analytical, The University of Sydney, Sydney, NSW 2006, Australia.
Suga H; Department of Chemistry, Graduate School of Science, The University of Tokyo, 7-3-1, Hongo, Tokyo 113-0033, Japan.
Payne RJ; School of Chemistry, The University of Sydney, Sydney, New South Wales 2006, Australia.; Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney, Sydney, New South Wales 2006, Australia.
Pokaż więcej
Źródło :
Journal of medicinal chemistry [J Med Chem] 2021 Jun 10; Vol. 64 (11), pp. 7853-7876. Date of Electronic Publication: 2021 May 27.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Factor XIIa/*antagonists & inhibitors
Peptides, Cyclic/*chemistry
RNA, Messenger/*metabolism
Serine Proteinase Inhibitors/*chemistry
Binding Sites ; Factor XIIa/metabolism ; Gene Library ; Genetic Code ; Humans ; Inhibitory Concentration 50 ; Kallikreins/chemistry ; Kallikreins/metabolism ; Molecular Dynamics Simulation ; Partial Thromboplastin Time ; Peptides, Cyclic/metabolism ; Protein Stability ; Prothrombin Time ; Puromycin/chemistry ; RNA, Messenger/chemistry ; Serine Proteinase Inhibitors/metabolism ; Structure-Activity Relationship
Czasopismo naukowe
Tytuł :
A predictive score for progression of COVID-19 in hospitalized persons: a cohort study.
Autorzy :
Xu J; Department of Hematology, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China. .
Wang W; Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
Ye H; Department of Hematology, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China.
Pang W; Department of Hematology, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China.
Pang P; Department of Interventional Therapy, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China.
Tang M; Department of Hematology, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China.
Xie F; Department of Hematology, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China.
Li Z; Department of Hematology, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China.
Li B; Department of Hematology, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China.
Liang A; Department of Rheumatology, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China.
Zhuang J; Department of Hematology, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China.
Yang J; Department of Hematology, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China.
Zhang C; Department of Hematology, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China.
Ren J; Department of Gastroenterology, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China.
Tian L; Department of Pharmacy, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China.
Li Z; Department of Nephrology, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China.
Xia J; Department of Infectious Diseases, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China.
Gale RP; Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, UK.
Shan H; Department of Interventional Therapy, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China. .
Liang Y; Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China. .
Pokaż więcej
Źródło :
NPJ primary care respiratory medicine [NPJ Prim Care Respir Med] 2021 Jun 03; Vol. 31 (1), pp. 33. Date of Electronic Publication: 2021 Jun 03.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19/*diagnosis
Hospitalization/*statistics & numerical data
Adolescent ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; C-Reactive Protein/analysis ; COVID-19/pathology ; Child ; Child, Preschool ; Disease Progression ; Female ; Humans ; Infant ; Logistic Models ; Male ; Middle Aged ; Oxygen/blood ; Prognosis ; Prothrombin Time ; ROC Curve ; Risk Assessment ; Sensitivity and Specificity ; Young Adult
Czasopismo naukowe
Tytuł :
Indication of Liver Transplantation in the Treatment of Newly Categorized Acute-on-Chronic Liver Failure In Japan.
Autorzy :
Kuramitsu K; Department of Surgery, Division of Hepato-Biliary and Pancreatic Surgery, Graduate School of Medicine, Kobe University, Kobe City, Hyogo, Japan. Electronic address: .
Yano Y; Department of Internal Medicine, Division of Gastroenterology, Graduate School of Medicine, Kobe University, Kobe City, Hyogo, Japan.
Komatsu S; Department of Surgery, Division of Hepato-Biliary and Pancreatic Surgery, Graduate School of Medicine, Kobe University, Kobe City, Hyogo, Japan.
Tanaka M; Department of Surgery, Division of Hepato-Biliary and Pancreatic Surgery, Graduate School of Medicine, Kobe University, Kobe City, Hyogo, Japan.
Kido M; Department of Surgery, Division of Hepato-Biliary and Pancreatic Surgery, Graduate School of Medicine, Kobe University, Kobe City, Hyogo, Japan.
Fukumoto T; Department of Surgery, Division of Hepato-Biliary and Pancreatic Surgery, Graduate School of Medicine, Kobe University, Kobe City, Hyogo, Japan.
Pokaż więcej
Źródło :
Transplantation proceedings [Transplant Proc] 2021 Jun; Vol. 53 (5), pp. 1611-1615. Date of Electronic Publication: 2021 May 06.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Liver Transplantation*
Acute-On-Chronic Liver Failure/*mortality
Hepatic Encephalopathy/*mortality
Liver/*injuries
Liver Failure, Acute/*mortality
Acute-On-Chronic Liver Failure/diagnosis ; Acute-On-Chronic Liver Failure/surgery ; Adult ; Aged ; Aged, 80 and over ; Female ; Hepatic Encephalopathy/diagnosis ; Hepatic Encephalopathy/surgery ; Humans ; Japan ; Liver Failure, Acute/diagnosis ; Liver Failure, Acute/surgery ; Male ; Middle Aged ; Multivariate Analysis ; Prothrombin Time ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
Anticoagulation in COVID-19 patients requiring continuous renal replacement therapy.
Autorzy :
Attallah N; Department of Nephrology, Medical Subspecialties Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates; Cleveland Clinic Lerner College of Medicine of Case Western University, Cleveland, Ohio, USA. Electronic address: .
Gupta S; Department of Nephrology, Medical Subspecialties Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Madhyastha R; Department of Nephrology, Medical Subspecialties Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
El Nekidy WS; Cleveland Clinic Lerner College of Medicine of Case Western University, Cleveland, Ohio, USA; Department of Pharmacy.
Mallat J; Cleveland Clinic Lerner College of Medicine of Case Western University, Cleveland, Ohio, USA; Critical Care Institute, Cleveland Clinic Abu Dhabi, United Arab Emirates.
Pokaż więcej
Źródło :
Anaesthesia, critical care & pain medicine [Anaesth Crit Care Pain Med] 2021 Jun; Vol. 40 (3), pp. 100841. Date of Electronic Publication: 2021 Mar 19.
Typ publikacji :
Letter
MeSH Terms :
Acute Kidney Injury/*therapy
Anticoagulants/*administration & dosage
COVID-19/*complications
Continuous Renal Replacement Therapy/*instrumentation
Filtration/*instrumentation
Heparin/*administration & dosage
Thrombosis/*prevention & control
COVID-19/blood ; Female ; Humans ; Male ; Middle Aged ; Prothrombin Time ; Retrospective Studies
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies